Shares of Bruker (NASDAQ: BRKR) experienced a sharp 5.26% drop during the pre-market session on Monday, August 4th, 2025, falling to $35.99 from the previous day’s closing price of $37.99. This significant decrease came after Bruker announced its Q2 2025 financial results, which revealed a miss on both earnings and revenue expectations.
Adjusted earnings were reported at $0.32 per share, missing the estimated $0.44 by a significant 27.27%, and marking a 38.46% decrease from the previous year’s earnings of $0.52. Revenue also fell short at $797.4 million, missing the expected $810.43 million by 1.61% and decreasing by 0.41% from the previous year’s revenue of $800.7 million.
